Schizophrenia 1
Therapeutic area
Psychiatry
Rare disease
No
- Definition
- A schizophrenia that has material basis in an autosomal dominant mutation of SCZD1 on chromosome 5q23-q35.
- Genetic basis
- Yes
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Schizophrenia 1
- Therapeutic area
- Psychiatry
- schizophrenia 1
- SCZD1
- schizophrenia 1
- Severity
- Severe
- Neurology
- Psychiatry
- MONDO ID
- MONDO:0008414
- Parent condition
- MONDO:0005090
Related records
Broader conditions (12)
- Brain disorder
- Central nervous system disorder
- Cognitive disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Mental disorder
- Nervous system disorder
- Psychiatric disorder
- Psychotic disorder
- Schizophrenia
Trials (28)
- A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
- A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia
- A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
- Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With Schizophrenia
- ACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia
- Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care
- Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia
- Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine)
- Cognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Pilot Randomized Waiting List Controlled Feasibility Study
- Comparison of the Italian and U.S. Forensic Models for Dual-diagnosis Offenders: a 3-year Longitudinal Study
- Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia
- Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis
- Disorders of the Sense of Self and Physical Activity
- Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients
- Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.
- Feasibility, Acceptability, and Effectiveness of a Hatha Yoga-in Patients Hospitalized for Schizophrenia
- Mindfulness-Based Yoga in Schizophrenia
- Multi-target TMS for Schizophrenia Negative Symptoms
- Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
- Online Intervention To Improve Motivation